Serum Institute Of India Ceo Adar Poonawalla

Billionaire CEO of Serum Institute of India, Adar Poonawalla, has sealed a deal to buy a multi-million-pound mansion in London's Mayfair, the Financial Times reported.

Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.

Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.

A day after the first indigenously developed Human Papillomavirus vaccine against cervical cancer was launched, Serum Institute of India CEO Adar Poonawalla on Wednesday said the vaccine will be available in small quantity this year.

Vaccine maker Serum Institute of India CEO Adar Poonawalla has called for global harmonisation or regulatory standards and said that cooperation among multilateral organisations is a must for dealing with future outbreaks.

Serum Institute of India CEO Adar Poonawalla on Sunday praised India's fight against the Covid pandemic, saying the government and the healthcare workers contributed largely to tackling the pandemic in the country.

Raising concern on the rising COVID-19 cases in neighbouring China, Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday asked the people not to panic because of India's "excellent vaccination coverage and track record".

Seven people have been arrested for allegedly using the image of Serum Institute of India CEO Adar Poonawalla and getting a director of the leading vaccine-producing firm to transfer Rs 1.01 crore to various bank accounts, Pune police said on Friday.

The Serum Institute of India will try to launch Omicron-specific vaccine for COVID-19 after six months, its CEO Adar Poonawalla said on Thursday.

Serum Institute of India CEO Adar Poonawalla on Tuesday said the company plans to launch its indigenously-developed vaccine to treat cervical cancer in women later this year after Drugs Controller General of India gives market authorisation.

Serum Institute of India (SII) CEO Adar Poonawalla tagged Elon Musk in a tweet and asked him to invest in India to manufacture Tesla electric cars, saying it will be the best investment he would have ever made.

Serum Institute of India (SII) CEO Adar Poonawalla on Sunday wooed Elon Musk to invest in India to manufacture Tesla electric cars, saying it will be the best investment he would have ever made.

Serum Institute of India CEO Adar Poonawalla on Friday warned against the return to the business-as-usual approach, saying we "can't afford to put a price tag on the life of a citizen" as the pandemic is not behind us yet.

Serum Institute of India (SII) CEO Adar Poonawalla today claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.

Serum Institute of India CEO Adar Poonawalla and Bharat Biotech cofounder Suchitra Ella today said that the decision was taken after discussions with the Centre.

Billionaire CEO of Serum Institute of India, Adar Poonawalla, has sealed a deal to buy a multi-million-pound mansion in London's Mayfair, the Financial Times reported.

Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.

Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.

A day after the first indigenously developed Human Papillomavirus vaccine against cervical cancer was launched, Serum Institute of India CEO Adar Poonawalla on Wednesday said the vaccine will be available in small quantity this year.

Vaccine maker Serum Institute of India CEO Adar Poonawalla has called for global harmonisation or regulatory standards and said that cooperation among multilateral organisations is a must for dealing with future outbreaks.

Serum Institute of India CEO Adar Poonawalla on Sunday praised India's fight against the Covid pandemic, saying the government and the healthcare workers contributed largely to tackling the pandemic in the country.

Raising concern on the rising COVID-19 cases in neighbouring China, Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday asked the people not to panic because of India's "excellent vaccination coverage and track record".

Seven people have been arrested for allegedly using the image of Serum Institute of India CEO Adar Poonawalla and getting a director of the leading vaccine-producing firm to transfer Rs 1.01 crore to various bank accounts, Pune police said on Friday.

The Serum Institute of India will try to launch Omicron-specific vaccine for COVID-19 after six months, its CEO Adar Poonawalla said on Thursday.

Serum Institute of India CEO Adar Poonawalla on Tuesday said the company plans to launch its indigenously-developed vaccine to treat cervical cancer in women later this year after Drugs Controller General of India gives market authorisation.

Serum Institute of India (SII) CEO Adar Poonawalla tagged Elon Musk in a tweet and asked him to invest in India to manufacture Tesla electric cars, saying it will be the best investment he would have ever made.

Serum Institute of India (SII) CEO Adar Poonawalla on Sunday wooed Elon Musk to invest in India to manufacture Tesla electric cars, saying it will be the best investment he would have ever made.

Serum Institute of India CEO Adar Poonawalla on Friday warned against the return to the business-as-usual approach, saying we "can't afford to put a price tag on the life of a citizen" as the pandemic is not behind us yet.

Serum Institute of India (SII) CEO Adar Poonawalla today claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.

Serum Institute of India CEO Adar Poonawalla and Bharat Biotech cofounder Suchitra Ella today said that the decision was taken after discussions with the Centre.